Do you see the dichotomy in those two statements?

Quote:

---

There’s nearly zero chance of a 47 patient trial getting approval by the FDA for HIV, regardless if its was approved by the FDA, a phase 3, and has a stat sig p value.

---

Quote:

---

They’ve been working with CYDY to combine the 47 patient combo trial with data from the monotherapy trial in order to gain approval. That’s a groundbreaking approach.

---